Early plasma exchange for progressive liver failure in recipients of adult-to-adult living-related liver transplants

Blood Purification

Volumn 28, Issue 1, 2009, Pages 40-46

  Yamamoto, Ryohei ^a   Nagasawa, Yasuyuki ^a   Marubashi, Shigeru ^a   Furumatsu, Yoshiyuki ^a   Iwatani, Hirotsugu ^a   Iio, Kenichiro ^a   Matsui, Isao ^a   Dono, Keizo ^a   Imai, Enyu ^a   Monden, Morito ^a   Isaka, Yoshitaka ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bilirubin; Living related liver transplant; Plasma exchange; Progressive liver failure

Indexed keywords

BILIRUBIN; CALCINEURIN INHIBITOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACCURACY; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE LIVER FAILURE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; BILIRUBIN; FEMALE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PLASMA EXCHANGE; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 62949174258     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210036     Document Type: Article

References (37)

1. Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, Ki-yosawa K, Ichida T:Successful living-related partial liver transplantation to an adult patient. Lancet 1994; 343:1233-1234.
2. Goldstein MJ, Salame E, Kapur S, Kinkhab-wala M, LaPointe-Rudow D, Harren NPP, Lobritto SJ, Russo M, Brown RS Jr, Catalde-girmen G, Weinberg A, Renz JF, Emond JC:Analysis of failure in living donor liver transplantation:differential outcomes in children and adults. World J Surg 2003; 27:356-364.
3. Yagi T, Urushihara N, Oishi M, Matsukawa H, Endo A, Nakao A, Okada Y, Sadamori H, Inagaki M, Matsuno T, Takakura N, Tanaka N:Problems in living donor liver transplantation in adults:postoperative management, complications, and costs. Transplant Proc 2000; 32:2156-2157.
4. Santoro A, Mancini E, Ferramosca E, Faenza S:Liver support systems. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 396-404.
5. Kellum JA, Venkataraman R:Application of blood purification to non-renal organ failure. Int J Artif Organs 2005; 28:445-449.
6. O'Beirne JP, Wendon JA:Liver support. Int J Ar tif Organs 2005; 28:477-481.
7. Kozaki K, Kasahara M, Oike F, Ogawa K, Fujimoto Y, Ogura Y, Ueda M, Kaihara S, Fukatsu A, Tanaka K:Apheresis therapy for living-donor liver transplantation:experience for apheresis use for living-donor liver transplantation at Kyoto University. Ther Apher 2002; 6:478-483.
8. Toft P, Schmidt R, Broechner AC, Nielsen BU, Bollen P, Olsen KE:Effect of plasma-pheresis on the immune system in endotox-in-induced sepsis. Blood Purif 2008; 26:145-150.
9. Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH:Systemic vascular resistance during high-volume plasmapher-esis in patients with fulminant hepatic failure:relationship with oxygen consumption. Eur J Gastroenterol Hepatol 1995; 7:887-892.
10. Kondrup J, Almdal T, Vilstrup H, Tygstrup N:High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 1992; 15:669-676.
11. Clemmesen JO, Gerbes AL, Gulberg V, Han-sen BA, Larsen FS, Skak C, Tygstrup N, Ott P:Hepatic blood f low and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis. He-patology 1999; 29:347-355.
12. Kawagishi N, Ohkohchi N, Fujimori K, Orii T, Chubachi S, Koyamada N, Watanabe M, Asakura T, Gotoh M, Satomi S:Indications and efficacy of apheresis for liver transplant recipients:experience of 16 cases in 34 living-related liver transplants. Transplant Proc 2000; 32:2111-2113.
13. Skerrett D, Mor E, Curtiss S, Mohandas K:Plasmapheresis in primary dysfunction of hepatic transplants. J Clin Apher 1996; 11:10-13.
14. Mandal AK, King KE, Humphreys SL, Maley WR, Burdick JF, Klein AS:Plasmapheresis:An effective therapy for primary allograft nonfunction after liver transplantation. Transplantation 2000; 70:216-220.
15. Haberal M, Ozdemir FN, Kaya S, Bilgin N:Beneficial effect of plasmapheresis on the outcome of transplant patients. Transplant Proc 1996; 28:2336.
16. Jones KD, Ferrell LD:Interpretation of biopsy findings in the transplant liver. Semin Diagn Pathol 1998; 15:306-317.
17. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC:Outcomes of 385 adult-to-adult living donor liver transplant recipients:a report from the A2ALL Consortium. Ann Surg 2005; 242:314-323, discussion 323-315.
18. Kamath PS, Wiesner RH, Malinchoc M, Kre-mers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR:A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
19. Urata K, Kawasaki S, Matsunami H, Hashi-kura Y, Ikegami T, Ishizone S, Momose Y, Komiyama A, Makuuchi M:Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21:1317-1321.
20. Jung A, Krisper P, Haditsch B, Stauber RE, Trauner M, Holzer H, Schneditz D:Bilirubin kinetic modeling for quantification of extra-cor poreal liver suppor t. Blood Purif 2006; 24:413-422.
21. DeLong ER, DeLong DM, Clarke-Pearson DL:Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach. Biometrics 1988; 44:837-845.
22. Youden WJ:Index for rating diagnostic tests. Cancer 1950; 3:32-35.
23. Holm S:A simple sequentially rejective multiple test procedure. Scand J Statistics 1979; 6:65-70.
24. Onaca NN, Levy MF, Sanchez EQ, Chinna-kotla S, Fasola CG, Thomas MJ, Weinstein JS, Murray NG, Goldstein RM, Klintmalm GB:A correlation between the pretransplan-tation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9:117-123.
25. Lepore MJ, Martel AJ:Plasmapheresis with plasma exchange in hepatic coma. Methods and results in five patients with acute fulminant hepatic necrosis. Ann Intern Med 1970; 72:165-174.
26. Shi Q, Gaylor JD, Cousins R, Plevris J, Hayes PC, Grant MH:The effects of serum from patients with acute liver fa ilure on the g row th and metabolism of Hep G2 cells. Artif Organs 1998; 22:1023-1030.
27. McCloskey P, Tootle R, Selden C, Larsen F, Roberts E, Hodgson HJ:Modulation of hepa-tocyte function in an immortalized human hepatocyte cell line following exposure to liver-failure plasma. Artif Organs 2002; 26:340-348.
28. Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, Gabazza EC, Adachi Y:Recent advances in bilirubin metabolism research:the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol 2000; 35:659-664.
29. Marubashi S, Dono K, Nagano H, Asaoka T, Hama N, Kobayashi S, Miyamoto A, Takeda Y, Umeshita K, Monden M:Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation. Liver Transpl 2007; 13:1538-1544.
30. Usami M, Nishimatsu S, Ohyanagi H, Shi-roiwa H, Takeyama Y, Kasahara H, Saitoh Y:Changes of serum bilirubin fraction in postoperative liver failure cases treated by plas-mapheresis:an effective marker for evaluation of bilirubin removal. Artif Organs 1991; 15:241-243.
31. Clemmesen JO, Kondrup J, Nielsen LB, Lar-sen FS, Ott P:Effects of high-volume plas-mapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol 2001; 96:1217-1223.
32. Ohyanagi H, Usami M, Kimata H, Saitoh Y:Therapeutic effect of plasma exchange with the biliary drainage in the treatment of obstructive jaundice. Artif Organs 1988; 12:394-401.
33. Watson R, Kozlowski T, Nickeleit V, Woosley JT, Schmitz JL, Zacks SL, Fair JH, Gerber DA, Andreoni KA:Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. Am J Transplant 2006; 6:3022-3029.
34. Rostron A, Carter V, Mutunga M, Cavanagh G, O'Suilleabhain C, Burt A, Jaques B, Talbot D, Manas D:A case of acute humoral rejection in liver transplantation:Successful treatment with plasmapheresis and mycophenolate mofetil. Transpl Int 2005; 18:1298-1301.
35. Ratner LE, Phelan D, Brunt EM, Mohanakumar T, Hanto DW:Probable antibody-mediated failure of two sequential ABO-compatible hepatic allografts in a single recipient. Transplantation 1993; 55:814-819.
36. Kawagishi N, Takeda I, Miyagi S, Satoh K, A kamatsu Y, Sekiguchi S, Fujimori K, Sato T, Satomi S:Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation. Ther Apher Dial 2007; 11:319-324.
37. Cruzado JM, Bestard O, Grinyo JM:Control of anti-donor antibody production post-transplantation:conventional and novel immunosuppressive therapies. Contrib Nephrol. Basel, Karger, 2009, vol 162, pp 117-128.